In fact, semaglutide, the active ingredient in Wegovy , Ozempic , and Rybelsus , may cause nausea in close to half of people taking Wegovy and up to 20% of people taking Ozempic or Rybelsus
In early trials, Retatrutide has shown substantial weight-loss potential among the highest recorded in metabolic-medication research
Customized Plan We combine injections with realistic dietary guidance and optional wellness therapies to enhance your results
Current medical guidance recommends against semaglutide during breastfeeding because the medication enters breast milk in animal studies and no human safety data exists
In 2024, state officials expanded Medicaid pilot programs to support chronic disease management, including obesity, for more Floridians